cyproterone acetate has been researched along with mdv 3100 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, X; Chen, C; Cui, S; Fu, Y; He, J; Hou, T; Li, D; Pang, J; Shan, L; Sun, H; Wang, X; Xu, L; Xu, X; Yang, L; Yang, Y; Yao, X; Zhou, W | 1 |
| Bastide, C; Bruyère, F; Guy, L; Karsenty, G; Rozet, F | 1 |
1 review(s) available for cyproterone acetate and mdv 3100
| Article | Year |
|---|---|
[Hormonal treatment in prostate cancer].
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Antineoplastic Agents, Hormonal; Benzamides; Combined Modality Therapy; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Estrogens, Non-Steroidal; Flutamide; Gonadotropin-Releasing Hormone; Humans; Imidazolidines; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Oligopeptides; Phenylthiohydantoin; Prostatectomy; Prostatic Neoplasms | 2013 |
1 other study(ies) available for cyproterone acetate and mdv 3100
| Article | Year |
|---|---|
Discovery of
Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Binding Sites; Cell Proliferation; Gene Expression; Humans; Male; Mice, SCID; Molecular Docking Simulation; Molecular Structure; Prostatic Neoplasms; Protein Transport; Receptors, Androgen; Structure-Activity Relationship; Sulfonamides; Xenograft Model Antitumor Assays | 2022 |